News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
Presentation TCT 2024 Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials Presenter: Lei Song October 30, 2024
Presentation TCT 2024 Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry Presenter: Stefano Galli October 30, 2024
Presentation TCT 2024 Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study Presenter: Frederic Bouisset October 30, 2024
Presentation TCT 2024 Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection? Presenter: Grzegorz Kaluza October 30, 2024
Presentation TCT 2024 Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer Presenter: Sahil Parikh October 30, 2024
Presentation TCT 2024 TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds Presenter: Jiasheng Yin October 27, 2024
News Conference News ESC 2024 ‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS Michael O'Riordan September 09, 2024
News Daily News FDA Medical Devices Chief Jeff Shuren Announces Retirement L.A. McKeown July 24, 2024
News Conference News ACC 2024 PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE L.A. McKeown April 08, 2024
News Conference News ISET 2024 Will IVUS Ever Take Off in Peripheral Vascular Interventions? Caitlin E. Cox January 31, 2024